Owen Mathre is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of biosynthetic methods, particularly in the production of glucosamine and N-acetylglucosamine. With a total of 2 patents, his work has implications for various industries, including pharmaceuticals and biotechnology.

Latest Patents

Mathre's latest patents focus on a biosynthetic method for producing glucosamine and N-acetylglucosamine. This innovative method involves the fermentation of genetically modified microorganisms to yield these valuable compounds. The patents also detail methods for recovering high-purity N-acetylglucosamine produced through fermentation, as well as a process to convert N-acetylglucosamine back into glucosamine. These advancements highlight the potential for more efficient and sustainable production methods in the industry.

Career Highlights

Throughout his career, Owen Mathre has worked with Arkion Life Sciences, LLC, and its Bio-Technical Resources Division. His experience in these organizations has allowed him to develop and refine his innovative approaches to biosynthetic production. His work has not only contributed to scientific knowledge but also to practical applications in the field.

Collaborations

Mathre has collaborated with notable colleagues such as Alan D. Grund and Thomas A. Jerrell, Jr. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Owen Mathre's contributions to the field of biosynthetic production are significant and impactful. His patents and career achievements reflect a commitment to advancing technology in the production of essential compounds. His work continues to influence the industry and pave the way for future innovations.